OS 테라퓨틱스(OSTX)는 NYSE MKT에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.62 (+1.25%), 시가총액 $0.08B, 52주 범위 $1.16 ~ $2.50.
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
OS 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
OS 테라퓨틱스의 현재 주가는 $1.62 (+1.25%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
OS 테라퓨틱스의 시가총액은 약 $0.08B입니다.
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the Un